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DNA sequence analysis of the bovine herpesvirus-1 (BHV-1) genome revealed the presence of an open reading frame
named UL1 which exhibited limited homology to glycoprotein gL of herpes simplex virus-1 (S. K. Khattar, S. van Drunen
Littel-van den Hurk, L. A. Babiuk, and S. K. Tikoo, Virology 213, 28 – 37). To identify the BHV-1 UL1 protein, rabbit antisera
were prepared against two synthetic peptides that were predicted by computer analysis to encompass antigenic epitopes.
Sera against both peptides immunoprecipitated a 16- to 17-kDa protein from in vitro translated in vitro transcribed mRNA,
BHV-1-infected MDBK cells, and purified virions. Enzymatic deglycosylation and lectin binding assays confirmed that the
BHV-1 UL1 protein contains only O-linked oligosaccharides and was named glycoprotein gL. Sera against UL22 protein
immunoprecipitated a protein of 108 kDa from BHV-1-infected MDBK cells and purified virions, which was modified only
by N-linked oligosaccharides and was named glycoprotein gH. Glycoprotein gL expressed by recombinant vaccinia virus
was properly processed and secreted into the medium. In contrast glycoprotein gH expressed by recombinant vaccinia
virus was found to be retained in the rough endoplasmic reticulum. However, gH coexpressed with gL by recombinant
vaccinia viruses was properly processed and transported to the cell surface, suggesting that complex formation between
gH and gL is necessary for the proper processing and transport of gH but not gL. In addition gH –gL complex formation
is also required for induction of neutralizing antibody response and anchoring of gL to the plasma membrane. q 1996
Academic Press, Inc.
Bovine herpesvirus-1 (BHV-1), an alphaherpesvirus replication in vitro (Liang et al., 1991; van Engelenburg
et al., 1994; Harrach, unpublished data), gD has been(Roizman et al., 1982), is a predominant cause of respira-
tory disease, abortion, and genital infections in cattle shown to be an essential component of the virion (Fehler
et al., 1992).(Yates, 1982). Like other herpesviruses, BHV-1 consists
of a nucleocapsid containing the linear double-stranded Glycoprotein gH, an essential component of the virion,
is found in all herpesviruses and constitutes the secondDNA genome, which is surrounded by an electron-dense
zone called the tegument and a lipid bilayer envelope. most highly conserved group of herpesviral glycopro-
teins. Homologs of gH have been found to be requiredIn this membrane are embedded the virus-encoded gly-
coproteins. These glycoproteins play an important role for penetration and cell to cell spread (Gompels and
Minson, 1986; Fuller et al., 1989; Haddad and Hutt-in the initial stages of virus–cell interactions and act as
major antigenic determinants for the humoral and cellular Fletcher, 1989; Peeters et al., 1992; Forrester et al., 1992).
In addition, antibodies against gH homologs possessimmune responses of the host. Although 10 glycoprotein
genes have been localized and sequenced in BHV-1 des- potent complement-independent neutralizing activity
(Buckmaster et al., 1984; Gompels and Minson, 1986;ignated gB, gC, gD, gE, gG, gH, gI, gK, gL, and gM,
only few have been characterized at the protein level Montalvo and Grose, 1986; Miller and Hutt-Fletcher,
1988; Fuller et al., 1989; Forrester et al., 1991; Gompels(reviewed by Tikoo et al., 1995; Khadr et al., 1996; Khattar
et al., 1995; Vlcek et al., 1995), all of which exhibit homol- et al., 1991). The expression of gH homologs in the ab-
sence of other virus proteins leads to the synthesis ofogy to respective glycoproteins of herpes simplex virus-
1. While gC, gE, gG, and gI are nonessential for virus the glycoprotein which is improperly transported and an-
tigenically different from native gH, suggesting that gH
homologs must interact with another viral protein in order
to attain proper structure and function (Gompels and Min-1 Published as VIDO Journal Series No. 206.
2 To whom correspondence and reprint requests should be ad- son, 1989; Foa-Tomasi et al., 1991; Gompels et al., 1991;
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accessory molecule named glycoprotein gL (Hutchinsonkatchewan, Canada S7N 5E3. Fax: (306) 966-7478. E-mail: Tikoo@
Sask.Usask.Ca. et al., 1992; Kaye et al., 1992; Roop et al., 1993; Liu et
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al., 1993) was identified as the viral protein that forms a (Hamilton, Ontario, Canada), while VSA3 is a proprietory
adjuvant of VIDO/Biostar (Saskatoon, SK, Canada).complex with gH, which is necessary for attaining proper
antigenic conformation and transport of gH.
BHV-1 gII/108, a glycoprotein of 108 kDa (van Drunen Cells and viruses
littel-van den Hurk et al., manuscript in preparation), is
Madin–Darby bovine kidney (MDBK) cells, human thy-the target of complement-independent neutralizing
midine kinase negative (TK0) cells, and BSC-1 cells weremonoclonal antibodies (MAbs) which inhibit penetration
grown as monolayers in Eagle’s minimum essential me-but do not prevent attachment of the virus to the cell
dium (MEM) supplemented with 5% fetal bovine serum.(Baranowski et al., 1993). gII/108 glycoprotein has been
LMTK0 cells were grown in Dulbecco’s MEM (DMEM)suggested to be involved in viral entry into the cell and
supplemented with 5% fetal bovine serum. Virus stocks ofin cell to cell spread of the virus (Baranowski et al., 1993).
BHV-1 were prepared in MDBK cells (Babiuk and Rouse,Preliminary evidence suggests that gII/108 may be the
1975). Wild-type vaccinia virus (VV) was propagated inhomolog of glycoprotein H (Baranowski et al., 1995; van
BSC-1 cells while recombinant VVs were cultivated inDrunen littel-van den Hurk et al., manuscript in prepara-
LMTK0 cells (Mackett et al., 1984).tion). However, in contrast to other herpesviruses, analy-
sis of purified labeled BHV-1 virions by immunoprecipita-
Antipeptide sera and other antibodiestion has suggested that gII/108 may not be a component
of the virion (Baranowski et al., 1993). In addition, no Two synthetic peptides, BUL1-1 (19 residues), repre-
other protein has been found associated with gII/108 senting amino acids 23 to 41, and BUL1-2 (16 residues),
glycoprotein (Baranowski et al., 1995). Since we recently representing amino acids 143 to 158 of UL1 ORF (Khattar
described the sequence of the BHV-1 UL1 gene that has et al., 1995), were synthesized onto a hydroxymethyl–
the potential to encode the homolog of HSV-1 glycopro- phenyl resin using an Applied Biosystems 430 A solid-
tein gL (Khattar et al., 1995), we sought to determine if phase peptide synthesizer employing Fmoc chemistry.
BHV-1 encodes a functional gL and whether it is neces- Rabbits were injected with 0.2 mg each of peptide conju-
sary for the correct transport and antigenicity of BHV-1 gated to keyhole limpet hemocyanin in Freund’s com-
glycoprotein gH. In this communication, we describe the plete adjuvant. Subsequent booster immunizations were
characterization of gH and gL glycoproteins and show given with 0.2 mg peptide conjugated to egg white oval-
that BHV-1 encodes a functional glycoprotein gL which bumin in RIBI adjuvant at 4-week intervals. MAbs (5C8,
forms a complex with gH and is required for proper post- 1A9, and 3E2) specific for UL22 protein were generated
translational modification and transport of gH. essentially as described previously (van Drunen Littel-
van den Hurk et al., 1984) except that the antigen used
MATERIALS AND METHODS for immunizing mice was envelope fraction of BHV-1 de-
pleted of major glycoproteins gB, gC, and gD. RabbitReagents and media
polyclonal serum specific for UL22 was prepared by in-
Cell culture media and fetal bovine serum were pur- jecting rabbits twice intramuscularly with 25 mg of affinity
chased from GIBCO/BRL (Burlington, Ontario, Canada). purified protein in VSA3.
Reagents for DNA manipulations and protein A–Sepha-
rose were purchased from Pharmacia (Dorval, Quebec, Plasmid constructions
Canada) and used as recommended by the manufac-
turer. The enzyme neuraminidase, 5*-bromo-2*-deoxyuri- The full-length UL1-encoding gene was excised from
a plasmid designated pSK2.2 [PTZ18R containing a 2.2-dine, biotinylated lectins, and other reagents for protein
analysis were obtained from Sigma Chemicals Co. (St. kb HindIII– NruI fragment (Khattar et al., 1995)] as a 600-
bp NlaIII– NheI fragment (blunt end repaired by T4 DNALouis, MO) and Pierce (Rockford, IL). The enzymes O-
glycosidase, PNGase F, and endo H were purchased polymerase) and inserted into NcoI (blunt end repaired
by mung bean nuclease) and SmaI-digested pTZ18RgIVfrom Boehringer Mannheim Canada (Laval, Quebec,
Canada). The Glycotrack kit was purchased from Oxford (Tikoo et al., 1993a), generating plasmid pSKgL. A 0.6-
kb BglII fragment derived from pSKgL was inserted intoBiosystems Ltd. (Rosedale, NY). The reagents for immu-
nofluorescence staining and other immunological assays BamHI-digested pSP64polyA, generating plasmid pSKiL,
and to BglII-digested pVVSL (Tikoo et al., 1993a), gener-were purchased from Zymed Laboratories Inc. (San Fran-
cisco, CA) and Bio-Rad (Mississauga, Ontario, Canada). ating plasmid pSKvL.
The 2.9-kb AvrII fragment containing the UL22 geneRadioisotopically labeled compounds and reagents for
fluorography were purchased from ICN, (Irvine, CA). Re- (Meyer et al., 1991) was excised from plasmid pSD106
(Mayfield et al., 1983), blunt end repaired with T4 DNAagents for in vitro transcription and translation including
plasmid pSP64polyA were purchased from Promega/ polymerase, and ligated to BamHI linkers. After BamHI
digestion of the ligation mixture, a 2.8-kb fragment wasFisher, Scientific Ltd. (Nepean, Ontario, Canada). RIBI
adjuvant was purchased from RIBI Immunochemicals purified and ligated to BamHI-digested pSP64polyA, gen-
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erating plasmid pSKiH, and to BglII-digested pVVSL (Ti- were subsequently transferred to nitrocellulose mem-
branes and reacted with UL1- or UL22-specific antise-koo et al., 1993a), generating plasmid pSKvH.
rum. Bound antibody was visualized after incubation of
In vitro transcription and translation membranes with biotinylated secondary antibody using
the strepavidin/biotinylated alkaline phosphatase com-
The 0.5–5.0 mg of plasmid DNA (pSKiL or pSKiH) was
plex catalyzed chromogenic reaction of the Bio-Rad im-
in vitro transcribed with SP6 polymerase as described
munoblot assay kit. For carbohydrate detection, the
by the supplier (Promega). RNA was translated in vitro
membranes were treated with periodate followed by bio-
for 2 hr at 307 using a rabbit reticulocyte lysate containing
tin–hydrazide (Glycotrack kit). For determining the type of
40 mCi of [35S]cysteine. Canine pancreatic microsomal
carbohydrate attached, the membranes were incubated
membranes were added to some reaction mixtures to
with a range of different biotinylated lectins. Finally, the
process the in vitro translated proteins. After synthesis,
biotinylated compounds were detected with streptavi-
the in vitro translated proteins were analyzed on sodium
din–alkaline phosphatase conjugate.
dodecyl sulphate (SDS)–polyacrylamide gels (PAGE)
with or without immunoprecipitation. Immunofluorescence
MDBK or LMTK0 cells were seeded and infected inRadiolabeling of cells and immunoprecipitation
four-well Lab-Tek chamber slides. The infected cells
For immunoprecipitation, LMTK0 cells were infected were fixed with either 2% paraformaldehyde for 15 min
with VVs at a multiplicity of infection of 5. After 90 min at 47 for surface staining or 100% methanol for 15 min at
of adsorption, the cells were washed and incubated in 0207 for internal staining. The cells were incubated with
cysteine-free DMEM for 3 hr before labeling with [35S]- rabbit antipeptide, rabbit antiprotein, or preimmune se-
cysteine (100 mCi/ml). After 4–8 hr of labeling, the cells rum and goat anti-rabbit immunoglobulin G conjugated
and/or media were harvested. BHV-1-infected MDBK to FITC and analyzed.
cells were labeled as described previously (van Drunen
Littel-van den Hurk et al., 1984). In pulse chase experi- Immunization of rabbit and antibody titer
ments, cells were labeled at 6 hr postinfection with 100 determination
mCi of [35S]cysteine for 30 min. Depending on the specific
Rabbits were immunized intraperitoneally with 0.2 mlexperiment, either the cells were harvested immediately
of 106 PFU of wild-type VV or recombinant VVs (SKgL oror the label was removed and the cells were incubated
SKgH) per milliliter at 0 and 21 days postinfection. Infor different time periods in DMEM containing an excess
addition, one group of rabbits was immunized with 0.2of cold cysteine (chase). Proteins were immunoprecipi-
ml of a suspension containing equal PFUs of recombi-tated from the medium or from infected cells lysed with
nant VVs SKgL and SKgH. Sera were obtained 2 weeksmodified radioimmunoprecipitation assay buffer and an-
after each immunization. BHV-1-specific total antibodyalyzed by SDS–PAGE as described previously (van Dru-
responses were measured by enzyme-linked immuno-nen Littel-van den Hurk et al., 1984).
sorbent assay (ELISA) (van Drunen Littel-van den Hurk
et al., 1984) with purified BHV-1 as an antigen. SerumIsolation of recombinant vaccinia viruses
neutralization antibody responses were determined as
The desired recombinant VVs were made by homolo- described previously (van Drunen Littel-van den Hurk et
gous recombination as previously described (Mackett et al., 1984), using 100 PFU of BHV-1. Titers were expressed
al., 1984), except that the linearized plasmid (pSKvL or as the reciprocals of the highest antibody dilution that
pSKvH) DNA was electroporated into the wild-type VV- caused a 50% reduction in number of plaques relative to
infected cells by using a Pharmacia Gene Pulser set at the control.
200 V and 500 mF. The recombinant VVs were identified
by screening TK0 plaques for the expression of recombi- RESULTS
nant proteins by immunocytochemistry (Tikoo et al., 1990)
Production of UL1 protein-specific antiserumbefore plaque purification and making viral stocks. The
recombinant VVs were named SKgL (expressing UL1
In order to identify and characterize the protein en-
protein) and SKgH (expressing UL22 protein).
coded by the UL1 gene, we made antipeptide serum.
Analysis of the UL1 gene product by an antigen programWestern blotting
(Hopp and Woods, 1981) of the PC/GENE software pack-
age identified two highly immunogenic regions, one siteAffinity purified protein, potassium tartrate gradient pu-
rified BHV-1, and recombinant VV-infected LMTK0 cells close to the amino terminus of the predicted protein and
one at the carboxy-terminal location. Peptide BUL1-1 ofwere suspended in modified lysis buffer and the proteins
were separated by SDS –PAGE (van Drunen Littel-van 19 amino acids corresponding to residues 23 to 41 and
peptide BUL1-2 of 16 amino acids corresponding to resi-den Hurk et al., 1984). For Western blotting the proteins
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were performed. Radiolabeled proteins from mock-in-
fected or BHV-1-infected cell lysates were immunopre-
cipitated and analyzed by SDS–PAGE. Compared to pre-
immune serum (Fig. 2A, lane b), both anti-BUL1-1 serum
(Fig. 2A, lane c) and anti-BUL1-2 serum (Fig. 2A, lane f)
recognized two protein species of 16 to 17 and 108 kDa.
Preincubation of anti-BUL1-1 serum with BUL1-1 peptide
inhibited detection (Fig. 2A, lane d), while addition of
peptide BUL1-2 had no effect (Fig. 2A, lane e). Similarly,
detection by anti-BUL1-2 peptide serum was inhibited by
preincubation of serum with peptide BUL1-2 (Fig. 2A,
FIG. 1. Immunoprecipitation of proteins synthesized by in vitro tran- lane g) but not with peptide BUL1-1 (Fig. 2A, lane h).
scription and translation of pSKiL and pSKiH plasmids. [35S]Cysteine- These proteins were not detected in uninfected cells (Fig.labeled in vitro translated pSkiL products (lane a), immunoprecipitated
2A, lane a). In addition, anti-UL22 serum also recognizedwith anti-BUL1-1 peptide serum (lane b) and preimmune serum (lane
the two protein species of 108 and 16 to 17 kDa (Fig.c); [35S]cysteine-labeled pSkiH products (lane d), immunoprecipitated
with anti-UL22 serum (lane e) and preimmune serum (lane f); and 2A, lane i). To determine if the 16- to 17- and 108-kDa
[35S]cysteine-labeled pSP64polyA products, immunoprecipitated with proteins are different and to examine if the anti-UL1 or
anti-BUL1-1 peptide serum (lane g) and anti-UL22 serum (lane h), were anti-UL22 serum cross-react with UL22 or UL1 proteins,separated on 12.5% SDS–PAGE under reducing conditions. The mol
respectively, we constructed recombinant VVs express-wt markers in kDa are indicated to the left.
ing UL1 (SKgL) or UL22 (SKgH) proteins. The anti-BUL1-
1 peptide serum (Fig. 2B, lane c) but not anti-UL22 serum
dues 143 to 158 of the predicted UL1 primary translation (Fig. 2B, lane d) recognized a 16- to 17-kDa protein ex-
product were synthesized and used for immunization of pressed in pSKgL VV-infected cells. The anti-UL22 serum
rabbits. Sera collected after the fourth boost were ana- (Fig. 2B, lane e) but not anti-BUL1-1 serum (Fig. 2B, lane
lyzed in detail. As shown below, sera against both pep- f) recognized a protein of 100 kDa (precursor of UL22
tides showed specific positive reactions. In contrast, protein) expressed in pSKgH VV-infected cells. These
none of the sera obtained after immunization of rabbits proteins were not detected in LMTK0 cells infected with
with an irrelevant peptide recognized any BHV-1-specific wild-type VV (Fig. 2B, lane b) or in uninfected cells (Fig.
proteins (data not shown). 2B, lane a). These results suggest that UL1 and UL22
proteins form a complex in BHV-1-infected cells which
In vitro translation and immunoprecipitation of UL1 is recognized by both anti-BUL1-1 and anti-UL22 sera.
and UL22 proteins
UL1 and UL22 proteins are not associated by
In order to determine the identity of UL1 and UL22 disulfide bonds
ORFs and to check whether the antibodies against these
gene products recognized their respective proteins, the To determine if the complex formation between UL1
two in vitro expression plasmids pSKiL and pSKiH were and UL22 proteins depended on interchain disulfide
generated in which the coding sequence of UL1 and bonds, the proteins from radiolabeled lysates of BHV-1-
UL22, respectively, was placed downstream of the SP6 infected MDBK cells were immunoprecipitated with anti-
promoter. In vitro translation of pSKiL RNA resulted in BUL1-1 (Fig. 3, lanes a and b) or anti-UL22 serum (Fig.
the synthesis of a polypeptide of 18 kDa (Fig. 1, lane a). 3, lanes c and d) and analyzed by SDS–PAGE under
The same protein was also recognized by anti-BUL1-1 reducing (Fig. 3, lanes a and c) and nonreducing (Fig. 3,
peptide serum (Fig. 1, lane b). Similarly, in vitro transla- lanes b and d) conditions. As seen in Fig. 3, both sera
tion of pSKiH RNA resulted in the synthesis of a polypep- clearly recognized two proteins of 108 and 16 to 17 kDa
tide of 92 kDa (Fig. 1, lane d) which was recognized by from BHV-1-infected MDBK cells when the proteins were
anti-UL22 serum (Fig. 1, lane e). However, these proteins analyzed by either reducing or nonreducing conditions.
were not immunoprecipitated with anti-UL1 peptide se- These results suggest that UL1 and UL22 proteins are
rum (Fig. 1, lane g) or anti-UL22 serum (Fig. 1, lane h) not associated by disulfide bonds.
from reactions in which pSP64polyA RNA was translated
The UL1 and UL22 proteins are glycosylatedin vitro. In addition, preimmune serum did not immuno-
precipitate any protein from the reactions containing
Sequence analyses of UL1 protein homologs of most
pSKiL (Fig. 1, lane c) or pSKiH (Fig. 1, lane f) RNAs.
alphaherpesviruses except pseudorabies virus (PRV)
show at least one N-linked glycosylation consensus se-In vivo expression of UL1 and UL22 proteins
quence (Kornfeld and Kornfeld, 1985; Davison and Scott,
1986; McGeoch et al., 1988; Telford et al., 1992; Klupp etTo further characterize the proteins and to confirm the
specificity of our antiserum, immunoprecipitation assays al., 1994). However, PRV and the BHV-1 UL1 do not show
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FIG. 2. In vivo expression of UL1 and UL22 proteins. (A) Proteins from lysates of [35S]cysteine-labeled mock-infected (lane a) or BHV-1-infected
(lanes b–i) MDBK cells were immunoprecipitated with preimmune serum (lane b), anti-BUL1-1 peptide serum (lanes a, c), anti-BUL1-1 peptide
serum preincubated with BUL1-1 peptide (lane d), anti-BUL1-1 serum preincubated with BUL1-2 peptide (lane e), anti-BUL1-2 peptide serum (lane
f), anti-BUL1-2 peptide serum preincubated with BUL1-2 peptide (lane g), anti-BUL1-2 peptide serum preincubated with BUL1-1 peptide (lane h),
and anti-UL22 serum (lane i) and were separated on 15% SDS–PAGE under reducing conditions. (B) Proteins from lysates of [35S]cysteine-labeled
LMTK0 cells mock-infected (lane a) or infected with wild-type vaccinia virus (lane b), recombinant VV SKgL (lanes c, d), and recombinant VV SKgH
(lanes e, f) were immunoprecipitated with anti-BUL1-1 peptide serum (lanes a–c, f) or anti-UL22 serum (lanes d, e) and separated on 12.5% SDS–
PAGE under reducing conditions. The mol wt markers in kDa are indicated to the left.
such a consensus sequence (Klupp et al., 1994; Khattar cosidase. No increase in the mobility of the protein was
et al., 1995). In vitro translation of in vitro transcribed observed following such treatment (Fig. 4A, lane e). Sec-
UL1 mRNA (Fig. 4A, lane a) in the presence of canine ond, attempts to label the protein with [3H]glucosamine
microsomal membranes did not show any decrease in were unsuccessful (data not shown). However, periodate
the mobility of UL1 protein (Fig. 4A, lane b). In addition, oxidation of UL1 protein detected carbohydrates (Fig. 4B,
treatment of UL1 protein with endo H (Fig. 4A, lane d) or lane b). So we tested different lectins with specificities
PNGase F (Fig. 4A, lane c) did not show any increase in for different carbohydrate groups for their ability to bind
the mobility of the protein. Together these results sug- to the protein. Only Dolichus biflorus lectin, which is spe-
gest that UL1 protein is not modified by N-linked oligo- cific for N-acetyl galactosamine [(GalNAc)-a-3GalNAc]
saccharides. Moreover, an increase in the mobility of bound to the UL1 protein (Fig. 4B, lane c). Treatment of
UL1 protein translated in vitro in the presence of canine the protein with neuraminidase and O-glycosidase (Fig.
microsomal membranes suggests that the signal se- 4B, lane d) but not PNGase F (Fig. 4B, lane e) caused
quence is cleaved (Fig. 4A, lane b). To determine whether the loss of D. biflorus lectin binding due to removal of
the UL1 protein contained O-linked oligosaccharides we sugar moieties. Since these data indicated that O-linked
treated the UL1 protein with neuraminidase and O-gly- oligosaccharides are attached to the UL1 protein, we
named the UL1 translational product BHV-1 glycoprotein
gL in accordance with the uniform nomenclature system
of alphaherpesvirus glycoproteins as described earlier
(Tikoo et al., 1995).
Homologs of the herpesvirus UL22 proteins have been
found to be glycosylated (Cranage et al., 1988; Gompels
and Minson, 1989; Klupp et al., 1992). An in vitro transla-
tion of in vitro transcribed UL22 mRNA (Fig. 4C, lane a)
in the presence of canine microsomal membranes
showed a decrease in mobility of UL22 protein (Fig. 4C,
lane b). UL22 protein synthesized in BHV-1-infected cells
was labeled by [3H]glucosamine (Fig. 4C, lane c). Treat-
ment of UL22 protein (Fig. 4D, lane a) with PNGase F
(Fig. 4D, lane b) but not with endo H (Fig. 4D, lane c),
FIG. 3. UL1 and UL22 proteins are not associated by disulfide bonds. neuraminidase (Fig. 4D, lane d), or neuraminidase and
Proteins from lysates of [35S]cysteine-labeled BHV-1-infected MDBK O-glycosidase (Fig. 4D, lane e) showed an increase in
cells were immunoprecipitated with anti-BUL1-1 serum (a, b) or anti- the mobility of the protein. None of the lectins specificUL22 serum (c, d) and separated on 10% SDS–PAGE under reducing
for O-linked oligosaccharides bound to the UL22 protein(a, c) or nonreducing (b, d) conditions. The mol wt markers in kDa are
indicated to the left. (data not shown). Taken together these results sug-
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BUL1-1 (lane b) and anti-UL22 sera (lane c) specifically
recognized 108- and 16- to 17-kDa virion proteins.
BHV-1 gL is required for proper processing and
transport of BHV-1 gH
Two types of experiments were performed to investi-
gate the processing of recombinant gH protein. (i) Pulse
chase studies were performed to study the maturation
of recombinant gH expressed by SKgH VV. (ii) Since
endo H sensitivity indicates the retention of protein in
the endoplasmic reticulum, endo H enzyme treatment
of steady-state-labeled proteins was done to investigate
whether the recombinant gH was retained in the endo-
plasmic reticulum (endo H sensitive) or transported to
the Golgi apparatus (endo H resistant), where N-linked
oligosaccharides are modified and O-linked oligosaccha-
rides are added.
Wild-type gH expressed by BHV-1-infected cells was
first detected as a 100-kDa precursor which was pro-
FIG. 4. Glycosylation of UL1 and UL22 proteins. (A) Immunoprecipita- cessed into a 108-kDa mature form of the protein (Fig.
tion of [35S]cysteine-labeled in vitro translated pSKiL RNA products
6A, panel 1). The mature form of wild-type gH (Fig. 6B,in the absence (lane a) or presence (lane b) of canine microsomal
lane a) was resistant to endo H enzyme treatment (Fig.membranes with anti-BUL1-1 peptide serum. 35S-labeled cytoplasmic
extracts from MDBK cells infected with BHV-1 were immunoprecipi- 6B, lane b), indicating that it entered the normal secretory
tated with anti-BUL1-1 peptide serum and treated with PNGase F (lane pathway through the Golgi apparatus, where N-linked
c), endo H (lane d), or neuraminidase and O-glycosidase (lane e). All oligosaccharides on gH were modified to the complex
these proteins were separated on 15% SDS–PAGE. (B) For lectin bind-
type prior to transport of gH to the cell surface. In con-ing, solublized purified BHV-1 virions (lanes a, b) or affinity purified UL1
trast, gH protein expressed by recombinant VV SKgHprotein (lanes c–e) were separated on 15% SDS–PAGE under reducing
conditions. The separated proteins were probed in Western blots with was detected as a precursor (100 kDa) which was never
anti-BUL1-1 peptide and anti-UL22 serum (lane a), oxidized with perio- processed into high-molecular-weight mature forms (Fig.
date and treated with biotin hydrazide (lane b) and probed before (lane 6A, panel 2). In addition, this recombinant protein (Fig.
c) or after digestion with neuraminidase and O-glycosidase (lane d) or
6B, lane c) was sensitive to endo H treatment (Fig. 6B,PNGase F (lane e) with biotinylated Dolicus biflorus lectin. (C) Immuno-
lane d), indicating that this protein contained N-linkedprecipitation of proteins from [35S]cysteine-labeled in vitro translated
pSKiH RNA in the absence (lane a) or presence (lane b) of canine oligosaccharides of the high-mannose type exclusively
microsomal membranes, or from lysates of [3H]glucosamine-labeled (Kornfeld and Kornfeld, 1985). These findings suggest
MDBK cells BHV-1 infected (lane c) or mock infected (lane d) by anti-
UL22 serum. Immunoprecipitated proteins were separated on 10%
SDS–PAGE under reducing conditions. (D) Proteins from [35S]cysteine-
labeled BHV-1-infected MDBK cells were immunoprecipitated with anti-
UL22 serum. The immunoprecipitated proteins were mock digested
(lane a) or treated with PNGase F (lane b), endo H (lane c), neuramini-
dase (lane d), or neuraminidase and O-glycosidase (lane e) and ana-
lyzed on 10% SDS–PAGE. The mol wt markers in kDa are indicated to
the left.
gested that the UL22 protein is modified by N-linked
oligosaccharides only and was named glycoprotein gH.
BHV-1 gL and gH are part of BHV-1 virions
In order to determine whether these two glycoproteins
are components of the virion, BHV-1 virions were labeled
FIG. 5. Identification of the BHV-1 gL and gH proteins in purifiedwith [35S]cysteine and purified by sucrose gradients. Puri-
virions. [35S]cysteine-labeled sucrose gradient purified BHV-1 virionsfied labeled virions were solubilized, and the proteins
were solubilized and proteins were immunoprecipitated with preim-
were immunoprecipitated by anti-BUL1-1 serum or anti- mune serum (lane a), anti-BUL1-1 serum (lane b), or anti-UL22 serum
UL22 serum and analyzed by SDS–PAGE. As seen in (lane c) and analyzed on 12.5% SDS–PAGE. The mol wt markers in
kDa are indicated to the left.Fig. 5, compared to preimmune serum (lane a), both anti-
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FIG. 6. Processing of glycoprotein gH. (A) BHV-1-infected MDBK cells (panel 1) or recombinant VV SKgH-infected LMTK0 cells (panel 2) were
pulse labeled with [35S]cysteine for 15 min (lane a) and chased for 15 (lane b), 30 (lane c), 60 (lane d), or 120 (lane e) min in unlabeled medium.
Cell extracts were immunoprecipitated with a UL22 MAb pool and analyzed by 12.5% SDS–PAGE under reducing conditions. (B) Proteins from
[35S]cysteine-labeled lysates of BHV-1-infected MDBK cells (lanes a, b) or recombinant VV SKgH-infected LMTK0 cells (lanes c, d) were immunoprecipi-
tated with anti-UL22 serum. Immunoprecipitated proteins were mock digested (lanes a, c) or treated with endo H (lanes b, d) and analyzed by 7.5%
SDS–PAGE under reducing conditions. (C) Proteins from [35S]cysteine-labeled lysates of mock-infected (lane a) or BHV-1-infected MDBK cells (lane
c), wild-type vaccinia virus-infected (lane b), recombinant VV SKgH-infected (lane d), and recombinant VV SKgH plus recombinant VV SKgL-infected
(lane e) LMTK0 cells were immunoprecipitated with anti-UL22 serum. Immunoprecipitated proteins from recombinant VVs SKgH- and SKgL-infected
LMTK0 cells were treated with endo H (lane f). Proteins were analyzed by 7.5% SDS–PAGE under reducing conditions. The mol wt markers in kDa
are indicated to the left.
that recombinant gH was not transported from the endo- face of the infected cells (Fig. 8f) or the culture media
(Fig. 9, lane b). In contrast, coexpression of gH and gLplasmic reticulum to the Golgi.
To determine if coexpression of gH and gL proteins would proteins resulted in the detection of gH on the surface
of the infected cells (Fig. 8h) but not in the culture mediahelp in proper processing and transport of recombinant gH,
LMTK0 cells were infected with SKgH or SKgL individually (Fig. 9, lane c), confirming that processing and transport
of gH is dependent on gL. Similarly, recombinant gL,or together. The radiolabeled proteins were immunoprecipi-
tated with anti-UL22 serum and analyzed by SDS–PAGE. when expressed alone, was detected intracellularly (Fig.
8c) but was not detected on the surface of the infectedCompared to gH alone (Fig. 6C, lane d) coexpression of gL
and gH results in the synthesis of a 108-kDa protein (mature
form) (Fig. 6C, lane e) that is indistinguishable from gH
synthesized in BHV-1-infected cells (Fig. 6C, lane c) and
which is resistant to endo H treatment (Fig. 6C, lane f). This
suggests that gH and gL form a complex which assists in
the processing and transport of gH.
To examine if the gH– gL complex formation was nec-
essary for the processing and transport of gL, radiola-
beled proteins from infected cell lysates were immuno-
precipitated with anti-BUL1-1 serum. As seen in Fig. 7A,
the electrophoretic mobility of recombinant gL synthe-
sized in SKgL-infected cells (lane d) was similar to au-
thentic gL produced in BHV-1-infected cells (lane c) or
FIG. 7. Processing of glycoprotein gL. (A) Proteins from lysates ofgL produced in SKgL- and SKgH-infected cells (lane b).
[35S]cysteine-labeled wild-type VV (lane a)-, recombinant VV SKgL (laneIn addition, recombinant gL produced in SKgL-infected
d)-, and recombinant VV SKgL plus recombinant VV SKgH (lane b)-
LMTK0 cells contained O-linked oligosaccharides (Fig. infected LMTK0 cells or BHV-1-infected MDBK cells (lane c) were immu-
7B, lane c). This suggests that gH is not required for noprecipitated with anti-BUL1-1 peptide serum and analyzed on 15%
SDS–PAGE under reducing conditions. (B) Proteins from lysates ofprocessing and transport of gL from the endoplasmic
mock-infected (lane d) cells, SKgL-infected LMTK0 cells (lanes b, c),reticulum to the Golgi.
or BHV-1-infected MDBK cells with (lane a) were separated on SDS–
PAGE under reducing conditions. After Western blotting, blots wereBHV-1 gL is not anchored independently to cell
probed with either anti-BUL1-1 serum (lane a) or biotinylated lectinmembranes
(Dolichos biflorus) before (lanes c, d) or after neuraminidase and O-
Recombinant gH when expressed alone, was detected glycanase treatment (lane b). The mol wt markers in kDa are indicated
to the left.intracellularly (Fig. 8e) but was not detected on the sur-
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FIG. 9. Secretion of glycoprotein gH and gL. [35S]Cysteine-labeled
culture medium from LMTK0 cells infected with recombinant SKgL (lane
a), recombinant SKgH (lane b), or recombinant SKgL plus SKgH (lanes
c, d) were immunoprecipitated with anti-BUL1-1 peptide serum (lanes
a, d), anti-UL22 serum (lanes b, c), or anti-BUL1-1 peptide serum (lane
a, d), and proteins were analyzed by 15% SDS–PAGE under reducing
conditions. The mol wt markers in kDa are shown to the left.
These results suggest that gL is membrane associated
as a result of its interaction with gH.
Immunogenicity of recombinant gH and gL proteins
In order to examine if complex formation between gH
and gL was necessary for the development of neutraliz-
ing antibody responses, rabbits were immunized with
the recombinant VVs SKgH and SKgL individually or in
combination. As shown in Table 1, ELISA titers were
detected in rabbits immunized with gH, gL, and gH–gL.
However, complement-independent serum neutralizing
antibody responses could only be detected in rabbits
immunized with gH–gL.
FIG. 8. Analysis of distribution of gH and gL glycoproteins. BHV-1-
TABLE 1infected MDBK cells infected with BHV-1 (a, b) or LMTK0 cells infected
with recombinant VV SKgL (c, d), recombinant VV SKgh (e, f), or recom- Serologic Response of Rabbits Immunized
binant VVs SKgH plus SKgL (g, h, i, j) were fixed either with 2% paraform- with Recombinant SKgL or SKgHa
aldehyde to detect protein on the surface of the cells (b, d, f, h, j) or
permeabilized with methanol to detect protein in the cells (a, c, e, g, ELISA antibody Virus-neutralizing
i). The fixed cells were treated with either anti-UL22 serum (a, b, e–h) Antigen titer b antibody titer c
or anti-BUL1-1 peptide serum (c, d, i, j) followed by fluorescein-conju-
gated goat anti-rabbit IgG. Mock-infected BHV-1 or LMTK0 cells, after Wild-type VV 10 2
fixing with paraformaldehyde or permeabilizing with methanol, looked Recombinant gL 160 2
similar to those in panel d. Recombinant gH 640 2
Recombinant gH plus gL 2560 16
a Rabbits were immunized intraperitoneally with 0.2 ml of 106 PFUcells (Fig. 8d). Coexpression of gL and gH resulted in
per milliliter at 0 and 21 days postinfection and sera were obtainedthe detection of gL on the surface of infected cells (Fig.
after 2 weeks of immunization.8j). However, gL was immunoprecipitated from the cul- b ELISA titers versus 0.1 mg of purified BHV-1 per well (van Drunen
ture media of cells infected with recombinant VV SKgL Littel-van den Hurk et al., 1984).
alone (Fig. 9, lane a) but not from cells coinfected with c Virus-neutralizing antibody titers versus 100 PFU of BHV-1 in the
absence of complement (van Drunen Littel-van den Hurk et al., 1984).the recombinant VVs SKgL and SKgH (Fig. 9, lane d).
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DISCUSSION brane anchor domain. A similar observation was made
earlier for human cytomegalovirus (CMV) gL (Spaete et
Several studies have shown that a novel glycoprotein al., 1993) and herpes simplex virus-1 (HSV-1) gL (Dubin
designated gL is encoded by members of all herpesvirus and Jiang, 1995).
subgroups, including alpha, beta, and gamma herpesvi- Previous studies have suggested that BHV-1 gII and
ruses, which is required for the correct processing and gp108 are identical proteins (van Drunen Littel-van den
transport of glycoprotein H (Hutchinson et al., 1992; Kaye Hurk et al., manuscript in preparation). Using cross-im-
et al., 1992; Liu et al., 1993; Yaswen et al., 1993; Spaete munoprecipitation with monoclonal antibodies to BHV-1
et al., 1993, Forgani et al., 1994). This glycoprotein com- gp108 and anti-UL22 peptide antiserum, it was sug-
plex (gH–gL) has been proposed to be essential for virus gested recently that gp108 is the product of the UL22
penetration and cell to cell spread. Although these two (gH) ORF (Baranowski et al., 1995). Our results involving
glycoproteins are structural components of all herpesvi- the expression of the UL22 gene in vitro and in vivo
ruses examined so far, the interaction between them confirm and extend the previous observations and pro-
differs among the different herpesviruses (Duus et al., vide further evidence that gp108, gII, and the translation
1995), suggesting that this complex may be involved in product of UL22, glycoprotein gH, are identical proteins
virus-specific interactions and thus may determine the and contain only N-linked oligosaccharides.
tropism of the virus. In this report we show that BHV-1 BHV-1 glycoproteins gB, gC, and gD expressed by re-
also encodes functional gL and gH glycoproteins, which combinant VVs are transported and processed similar to
are structural components of virion and form a complex the authentic glycoproteins produced in BHV-1-infected
which appears to be required for the proper processing, cells (van Drunen Littel-van den Hurk et al., 1989; Tikoo
transport, and antigenicity of gH and anchoring of gL on et al., 1993a,b). However, the characteristics of gH ex-
the cell surface. pressed by recombinant VV SKgH differed from those
The BHV-1 UL1 gene has been suggested to encode of authentic gH produced in BHV-1-infected cells. The
a protein of 158 amino acids which is predicted to contain recombinant gH was slightly smaller, possessed endo
an N-terminal signal sequence with no potential site(s) H-sensitive glycans, and was not transported to the cell
for the addition of N-linked oligosaccharides (Khattar et surface. This is unlikely to be due to some anomaly in
al., 1995). Two different antipeptide sera immunoprecipi- the vaccinia virus expression system since similar re-
tated a protein of 16 to 17 kDa from BHV-1-infected cells sults were found with BHV-1 gH expressed by
and purified virions which we designated glycoprotein transfected MDBK cells (unpublished results). This de-
gL based on following observations: (i) the BHV-1 UL1 fect in intracellular transport appears to be a conserved
gene is a positional homolog of the other herpesvirus feature of herpesvirus gH homologs, including HSV-1
glycoprotein gL, (ii) the N-terminal hydrophobic region of (Gompels and Minson, 1989).
the BHV-1 UL1 protein acts as a signal sequence as it The proper processing and transport of recombinant
is cleaved, (iii) the BHV-1 UL1 protein is glycosylated, gH could be restored by coexpression of gH with gL.
and (iv) the BHV-1 UL1 protein is functionally equivalent Further evidence that gH and gL form a complex comes
to glycoprotein gL of other herpesviruses. BHV-1 gL does from the observation that both glycoproteins were im-
not need any other viral protein for its posttranslational munoprecipitated from BHV-1-infected cells with either
processing, since cells infected with recombinant V V anti-gH or anti-gL serum. This gH – gL interaction ap-
SKgL secrete gL which is indistinguishable from gL pro- pears to be noncovalent since the same molecular
duced in BHV-1-infected cells or in cells transfected with weight proteins were detected by PAGE analysis under
gL (data not shown). In contrast, a recent report suggests reducing and nonreducing conditions. Although similar
that HSV-1 gL produced in transfected cells (Dubin and gH – gL complex formation has been observed in other
Jiang, 1995) is processed differently than gL produced in herpesviruses, the nature of the interactions differ. For
recombinant VV-infected cells (Hutchinson et al., 1992). example, the HSV-1 gH is associated noncovalently with
However, BHV-1 gL does need a glycoprotein for its gL (Hutchinson et al., 1992; Kaye et al., 1992) and CMV
association with the plasma membrane. Three lines of gH is associated with gL by disulfide linkages (Spaete
evidence suggest that glycoprotein gH is required for the et al., 1993).
anchoring of gL to the plasma membrane: (i) there is no Like other herpesvirus gH proteins, BHV-1 gH has
other hydrophobic domain in gL which might serve as been suggested to be involved in virus penetration, cell
putative transmembrane anchor except the N-terminal to cell spread, and induction of neutralizing antibodies
signal sequence, which is cleaved in the mature form; (Baranowski et al., 1993). Using an affinity purified gH:gL
(ii) gL is secreted from cells infected with recombinant complex, we demonstrated that preincubation of cells
VV SKgL but not from cells coinfected with recombinant with the complex prevented virus penetration but did not
VV SKgL and SKgH; and (iii) cell surface expression of prevent virus attachment (van Drunen Littel-van den Hurk
gL results from complex formation with gH, which has a et al., manuscript in preparation). In addition, neutralizing
antibodies could be detected in sera of rabbits immu-well-defined carboxy-terminal hydrophobic transmem-
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processed in cells infected with deletion or ts mutants in the knownnized with both recombinant VV SKgL and recombinant
HSV glycoproteins. Virology 180, 474–482.VV SKgH but not when the rabbits were immunized with
Forghani, B., Ni, L., and Grose, C. (1994). Neutralization epitope of the
individual recombinant VV. These results clearly sug- varicella-zoster virus gH:gL glycoprotein complex. Virology 199, 458–
gested that formation of the gH–gL complex is necessary 462.
Forrester, A. J., Farrell, H., Wilkinson, G., Kaye, J., Davis-Poynter, N.,for the biological and immunological functions of gH.
and Minson, A. C. (1992). Construction and properties of a mutantHowever, it is not clear what the contribution of gL is
of herpes simplex virus type 1 with glycoprotein H coding sequencesto these biological and immunological functions. It is
deleted. J. Virol. 66, 341–348.
possible that a functional domain composed of parts of Forrester, A. J., Sullivan, V., Simmons, A., Blacklaws, B. A., Smith, G. L.,
both gH and gL is produced as a result of their interac- Nash, A. A., and Minson, A. C. (1991). Induction of protective immunity
with antibody to herpes simplex virus type 1 glycoprotein H (gH) andtion. Alternatively, gL may be helping gH in attaining the
analysis of the immune response to gH expressed in recombinantbiologically active configuration and thus may not be
vaccinia virus. J. Gen. Virol. 72, 369–375.directly involved in these functions. Experiments are in
Fuller, A. O., Santos, R., and Spear, P. (1989). Neutralizing antibodies
progress to prove or refute these alternatives. specific for glycoprotein H of herpes simplex virus permit viral attach-
ment to cells but prevent penetration. J. Virol. 63, 3435–3443.
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